600 related articles for article (PubMed ID: 27261337)
1. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus.
Fock KM; Talley N; Goh KL; Sugano K; Katelaris P; Holtmann G; Pandolfino JE; Sharma P; Ang TL; Hongo M; Wu J; Chen M; Choi MG; Law NM; Sheu BS; Zhang J; Ho KY; Sollano J; Rani AA; Kositchaiwat C; Bhatia S
Gut; 2016 Sep; 65(9):1402-15. PubMed ID: 27261337
[TBL] [Abstract][Full Text] [Related]
2. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
3. Barrett's oesophagus: optimal strategies for prevention and treatment.
Fass R; Sampliner RE
Drugs; 2003; 63(6):555-64. PubMed ID: 12656653
[TBL] [Abstract][Full Text] [Related]
4. Systematic review with meta-analysis: risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms.
Eusebi LH; Telese A; Cirota GG; Haidry R; Zagari RM; Bazzoli F; Ford AC
Aliment Pharmacol Ther; 2021 May; 53(9):968-976. PubMed ID: 33705573
[TBL] [Abstract][Full Text] [Related]
5. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
Shearer C; Going J; Neilson L; Mackay C; Stuart RC
Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
8. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
Sharma P
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
[TBL] [Abstract][Full Text] [Related]
9. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
10. Acid suppression and surgical therapy for Barrett's oesophagus.
de Jonge PJ; Spaander MC; Bruno MJ; Kuipers EJ
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):139-50. PubMed ID: 25743462
[TBL] [Abstract][Full Text] [Related]
11. Management of Gastroesophageal Reflux Disease in Asian Countries: Results of a Questionnaire Survey.
Hojo M; Nagahara A; Hahm KB; Iwakiri R; Watanabe T; Rani AA; Zhu Q; Chan FKL; Sollano JD; Kamiya T; Yamaguchi S; Motoya S; Fock KM; Fukudo S; Kachintorn U; Suzuki H; Murakami K;
Digestion; 2020; 101(1):66-79. PubMed ID: 31801133
[TBL] [Abstract][Full Text] [Related]
12. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Fitzgerald RC; di Pietro M; O'Donovan M; Maroni R; Muldrew B; Debiram-Beecham I; Gehrung M; Offman J; Tripathi M; Smith SG; Aigret B; Walter FM; Rubin G; ; Sasieni P
Lancet; 2020 Aug; 396(10247):333-344. PubMed ID: 32738955
[TBL] [Abstract][Full Text] [Related]
13. Barrett's oesophagus.
Navaratnam RM; Winslet MC
Postgrad Med J; 1998 Nov; 74(877):653-7. PubMed ID: 10197195
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of Barrett's oesophagus. A general survey.
Petrakis IE; Sciacca V; Iascone C
Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
[TBL] [Abstract][Full Text] [Related]
15. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L
Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223
[TBL] [Abstract][Full Text] [Related]
16. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.
Armstrong D; Marshall JK; Chiba N; Enns R; Fallone CA; Fass R; Hollingworth R; Hunt RH; Kahrilas PJ; Mayrand S; Moayyedi P; Paterson WG; Sadowski D; van Zanten SJ;
Can J Gastroenterol; 2005 Jan; 19(1):15-35. PubMed ID: 15685294
[TBL] [Abstract][Full Text] [Related]
17. Barrett's oesophagus: epidemiology, diagnosis and clinical management.
Whiteman DC; Kendall BJ
Med J Aust; 2016 Oct; 205(7):317-24. PubMed ID: 27681974
[TBL] [Abstract][Full Text] [Related]
18. Barrett's metaplasia in Indian obese male patients with gastro-oesophageal reflux disease.
Bamanikar AA; Diwan AG; Benoj DE; Bamanikar SA
J Indian Med Assoc; 2011 Jul; 109(7):483-4. PubMed ID: 22315840
[TBL] [Abstract][Full Text] [Related]
19. Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease.
Britton J; Gadeke L; Lovat L; Hamdy S; Hawkey C; McLaughlin J; Ang Y
Lancet Gastroenterol Hepatol; 2017 Nov; 2(11):824-831. PubMed ID: 28867477
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
